Last reviewed · How we verify
LY2189265 and Lifestyle Measures
LY2189265 and Lifestyle Measures is a Small molecule drug developed by Eli Lilly and Company. It is currently in Phase 2 development. Also known as: Dulaglutide.
At a glance
| Generic name | LY2189265 and Lifestyle Measures |
|---|---|
| Also known as | Dulaglutide |
| Sponsor | Eli Lilly and Company |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LY2189265 and Lifestyle Measures CI brief — competitive landscape report
- LY2189265 and Lifestyle Measures updates RSS · CI watch RSS
- Eli Lilly and Company portfolio CI
Frequently asked questions about LY2189265 and Lifestyle Measures
What is LY2189265 and Lifestyle Measures?
LY2189265 and Lifestyle Measures is a Small molecule drug developed by Eli Lilly and Company.
Who makes LY2189265 and Lifestyle Measures?
LY2189265 and Lifestyle Measures is developed by Eli Lilly and Company (see full Eli Lilly and Company pipeline at /company/eli-lilly).
Is LY2189265 and Lifestyle Measures also known as anything else?
LY2189265 and Lifestyle Measures is also known as Dulaglutide.
What development phase is LY2189265 and Lifestyle Measures in?
LY2189265 and Lifestyle Measures is in Phase 2.
Related
- Manufacturer: Eli Lilly and Company — full pipeline
- Also known as: Dulaglutide
- Compare: LY2189265 and Lifestyle Measures vs similar drugs
- Pricing: LY2189265 and Lifestyle Measures cost, discount & access